Steven Ortman
Primary Care · Tulsa, OKNPI 1215529243
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 140 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $678 and has fallen 50.4% since, to $336 in 2025.
Across 140 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$564
- Averitas Pharma Inc.$483
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$449
- Scilex Pharmaceuticals Inc.$169
- GRT US Holding, Inc.$134
- Merck$126
- plus $529 from 18 others
What the payments were for
- Food & beverage$2,453100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 32 | $564 |
| Averitas Pharma Inc. | 25 | $483 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $449 |
| Scilex Pharmaceuticals Inc. | 10 | $169 |
| GRT US Holding, Inc. | 9 | $134 |
| Merck | 9 | $126 |
| Medtronic | 2 | $71 |
| Arbor Pharmaceuticals, Inc. | 3 | $53 |
| AbbVie | 3 | $51 |
| Abiomed | 1 | $45 |
| Baxter Healthcare | 1 | $37 |
| Saluda Medical Americas, Inc. | 1 | $33 |
| Boston Scientific | 2 | $31 |
| Eisai Inc. | 2 | $29 |
| Azurity Pharmaceuticals, Inc. | 2 | $28 |
| UCB, Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Orexo US, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Valinor Pharma, LLC | 1 | $14 |
| Vertex | 1 | $14 |
| Baudax Bio Inc. | 1 | $13 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Qutenza$159
How this compares
$2,453 in reported general payments places this provider in the 85th percentile of 83 primary care providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other primary care in Tulsa
- Cristina SarrosaTulsa$6K
- Stephanie PennieTulsa$3K
- Ziva CooperTulsa$460
- Linda WilliamsTulsa$399
- Molly BartTulsa$360
- Teri RatzTulsa$300
- Ralynda RozellTulsa$284
- Aimee MusgroveTulsa$235
- Amber MaharSallisaw$9K
- Misty DeanOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.